Cargando…
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
BACKGROUND: Cancer patients have been reported to be at higher risk of COVID-19 complications and deaths. We report the characteristics and outcome of patients diagnosed with COVID-19 during breast cancer treatment at Institut Curie hospitals (ICH, Paris area, France). METHODS: An IRB-approved prosp...
Autores principales: | Vuagnat, Perrine, Frelaut, Maxime, Ramtohul, Toulsie, Basse, Clémence, Diakite, Sarah, Noret, Aurélien, Bellesoeur, Audrey, Servois, Vincent, Hequet, Delphine, Laas, Enora, Kirova, Youlia, Cabel, Luc, Pierga, Jean-Yves, Bozec, Laurence, Paoletti, Xavier, Cottu, Paul, Bidard, François-Clément |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254663/ https://www.ncbi.nlm.nih.gov/pubmed/32460829 http://dx.doi.org/10.1186/s13058-020-01293-8 |
Ejemplares similares
-
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
por: Basse, Clémence, et al.
Publicado: (2021) -
Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study
por: Ramtohul, Toulsie, et al.
Publicado: (2020) -
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals
por: Chalumeau, Clelia, et al.
Publicado: (2022) -
Pretreatment Tumor Growth Rate and Radiological Response as Predictive Markers of Pathological Response and Survival in Patients with Resectable Lung Cancer Treated by Neoadjuvant Treatment
por: Ramtohul, Toulsie, et al.
Publicado: (2023) -
Première vague COVID-19 : expérience d’un centre de lutte contre le cancer
por: Frelaut, Maxime, et al.
Publicado: (2021)